OBJECTIVE: To assess the outcome of a regimen of a reduced dose of mifepristone
followed by one or two doses of vaginal misoprostol as a non-surgical method for …

OBJECTIVES: To compare the experience of pain, need of analgesic interventions,
preference and acceptability in medical abortion up to 49 days of amenorrhea with …

Background Medical termination of pregnancy can be successfully performed with a
combination of mifepristone (RU 486) and a prostaglandin analogue. We conducted a …

BACKGROUND: From 2001 to March 2006, Planned Parenthood Federation of America
(Planned Parenthood) health centers throughout the United States provided medical …

DESIGN: A retrospective analysis of 386 women who underwent termination of pregnancy
between 12 and 24 weeks' gestation. METHODS: Each woman received 200 mg …

BACKGROUND: Several studies have now reported the successful use of the sublingual
administration of misoprostol for medical abortion in the first trimester. The objective of this …

Objective: The purpose of this study was to compare the abortifacient effect of intravaginally
administered moistened misoprostol tablets with that of the combination regimen of …

OBJECTIVE: To review published reports of first-trimester medical abortion regimens that do
not include mifepristone. METHODS: Reports listed in Pubmed and Medline on prospective …

BACKGROUND The conventional timing of misoprostol administration after mifepristone for
second trimester medical abortion is 36–48 h, but simultaneous administration, which may …

BACKGROUND: The dose of mifepristone approved by most government agencies for
medical abortion is 600 mg. Our aim was to summarize extant data on the effectiveness and …